Genetic variants of myeloperoxidase and lung cancer risk

Carcinogenesis

Volumn 21, Issue 6, 2000, Pages 1163-1166

  Schabath, Matthew B ^a,b   Spitz, Margaret R ^a   Zhang, Xinmei ^a   Delclos, George L ^b   Wu, Xifeng ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME VARIANT; MYELOPEROXIDASE;

ADULT; AGE; AGED; ALLELE; ARTICLE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENDER; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS;

EID: 0034122634     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.163     Document Type: Article

References (30)

1. DeBethizy, J.D. and Hayes, J.R. (1994) Metabolism: a determinant of toxicity. In Hayes, W.A. (ed.) Principles and Methods of Toxicology, 3rd Edn. Raven Press, New York, NY, pp. 59-100.
2. Hecht, S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-1210.
3. Klebanoff, S.J. (1991) Myeloperoxidase: occurrence and biological function. In Everse, J. Everse, K.E. and Grisham, M.B. (eds) Peroxidases in Chemistry and Biology. CRC Press, Boca Raton, FL, Vol. 1, pp. 1-35.
4. Mallet, W.G., Mosebrook, D.R. and Trush, M.A. (1991) Activation of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase. Carcinogenesis, 12, 521-524.
5. Trush, M.A., Seed, J.L. and Kensler, T.W. (1985) Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: possible link between inflammation and cancer. Proc. Natl Acad. Sci. USA, 82, 5194-5198.
6. Hunninghake, G.W. and Crystal, R.G. (1983) Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am. Rev. Respir. Dis., 128, 833-838.
7. Schmekel, B. and Venge, P. (1991) The distribution of myeloperoxidase, eosinophil cationic protein, albumin and urea in sequential bronchoalveolar lavage. Eur. Respir. J., 4, 517-523.
8. Schmekel, B., Karlsson, S.E., Linden, M., Sundstrom, C., Tegner, H. and Venge, P. (1990) Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation, 14, 447-454.
9. Petruska, J.M., Mosebrook, D.R., Jakab, G.J. and Trush, M.A. (1992) Myeloperoxidase-enhanced formation of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis, 13, 1075-1081.
10. Austin, G.E., Lam, L., Zaki, S.R., Chan, W.C., Hodge, T., Hou, J., Swan, D., Zhang, W., Racine, M., Whitsett, C. et al. (1993) Sequence comparison of putative regulatory DNA of the 5′ flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells. Leukemia, 7, 1445-1450.
11. Piedrafita, F.J., Molander, R.B., Vansant, G., Orlova, E.A., Pfahl, M. and Reynolds, W.F. (1996) An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem., 271, 14412-14420.
12. Reynolds, W.F., Chang, E., Douer, D., Ball, E.D. and Kanda, V. (1997) An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood, 90, 2730-2737.
13. Witko-Sarsat, V., Allen, R.C., Paulais, M., Nguyen, A.T., Bessou, G., Lenoir, G. and Descamps-Latscha, B. (1996) Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J. Immunol., 157, 2728-2735.
14. Nagra, R.M., Becher, B., Tourtellotte, W.W., Antel, J.P., Gold, D., Paladino, T., Smith, RA., Nelson, J.R. and Reynolds, W.F. (1997) Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol., 78, 97-107.
15. Pero, R.W., Sheng, Y., Olsson, A., Bryngelsson, C. and Lund-Pero, M. (1996) Hypochlorous acid/N-chloramines are naturally produced DNA repair inhibitors. Carcinogenesis, 17, 13-18.
16. Van Rensburg, C.E., Van Staden, A.M., Anderson, R. and Van Rensburg, E.J. (1992) Hypochlorous acid potentiates hydrogen peroxide-mediated DNA-strand breaks in human mononuclear leucocytes. Mutat. Res., 265, 255-261.
17. London, S.J., Lehman, T.A. and Taylor, J.A. (1997) Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res., 57, 5001-5003.
18. Hudmon, K.S., Honn, S.E., Jiang, H., Chamberlain, R.M., Xiang, W., Ferry, G., Gosbee, W., Hong, W.K. and Spitz, M.R. (1997) Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol. Biomarkers Prev., 6, 565-571.
19. Wu, X., Hsu, T.C., Cao, S., Lee, J.J., Amos, C.I. and Spitz, M.R. (1998) Deletion in poly(ADP-ribose) polymerase pseudogene and lung cancer risk. Carcinogenesis, 19, 93-98.
20. STATA Corporation (1995) STATA Release 3.1 Reference Manual, 6th Edn. STATA Corp.. College Station, TX.
21. Woolf, B. (1955) On estimating the relation between blood group and disease. Annu. Hum. Genet., 19, 251-253.
22. Daugherty, A., Dunn, J.L., Rateri, D.L. and Heinecke, J.W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest., 94, 437-444.
23. Reynolds, W.F., Rhees, J., Maciejewski, D., Paladino, T., Sieburg, H., Maki, R.A. and Masliah, E. (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol., 155, 31-41.
24. Zang, E.Z. and Wynder, E.L. (1996) Differences in lung cancer risk between men and women: examination of the evidence. J. Natl Cancer Inst., 88, 183-192.
25. Ryberg, D., Hewer, A., Phillips, D.H. and Haugen, A. (1994) Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res., 54, 5801-5803.
26. Kato, R. (1974) Sex-related differences in drug metabolism. Drug Metab. Rev., 3, 1-32.
27. Lee, R.P. and Forkert, P.G. (1995) Pulmonary CYP2E1 bioactivates 1,1-dichloroethylene in male and female mice. J. Pharmacol. Exp. Ther., 273, 561-567.
28. Schenkman, J.B., Frey, I., Remmer, H. and Estabrook, R.W. (1967) Sex differences in drug metabolism by rat liver microsomes. Mol. Pharmacol., 3, 516-525.
29. Wei, Q., Cheng, L., Hong, W.K. and Spitz, M.R. (1996) Reduced DNA repair capacity in lung cancer patients. Cancer Res., 56, 4103-4107.
30. Wu, X., Gu, J., Amos, C.I., Jiang, H., Hong, W.K. and Spitz, M.R. (1998) A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Cancer, 83, 1118-1127.